The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.6890 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Matthew A Shear und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Genetic Testing, Fetal Therapies, Prenatal Diagnosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, US National Human Genome Research Institute, UCSF Center for Maternal Fetal Precision Medicine.
Abstract (Originalsprache)
In utero interventions are transformative in addressing genetic and anatomic conditions during fetal development. Next generation sequencing enables early genetic testing, playing a pivotal role in prenatal decision‐making by supporting risk stratification, precise and timely diagnosis, which directly informs eligibility for fetal surgical and molecular therapies. Early diagnosis benefits both prenatal and postnatal care by guiding prenatal interventions, or selecting cases that might benefit from postnatal preparedness (when early postnatal treatment alters outcomes), and informing counseling (when it significantly influences pregnancy decision‐making) and reproductive planning. The integration of artificial intelligence into prenatal care holds the promise of end‐to‐end solutions that streamline diagnosis, counseling, and access to both standard and experimental in utero interventions. However, significant ethical and social challenges remain, including equity in access to testing and care, incidental findings, variants of uncertain significance, incomplete penetrance and uncertain phenotype prediction of rare variants and disorders. These complexities raise important questions about reproductive autonomy and justice and responsible use of emerging technologies. This review emphasizes the intimate interplay between early genetic testing and in utero interventions, while highlighting the need for equitable, precise, and community‐informed practices in prenatal genomic research and care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, San Francisco, California, USA.
- Division of Maternal Fetal Medicine and Reproductive Genetics, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California, USA.
- Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA.
- Department of Surgery, University of California, San Francisco, San Francisco, California, USA.
- Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, North Carolina, USA.
- Bioethics Program, University of California, San Francisco, San Francisco, California, USA.
ORCID-Profile: Matthew A Shear, Beltran Borges, Emma Canepa, Jennifer L Cohen, Julia E H Brown, Akos Herzeg
Förderung
- NHGRI NIH HHS
- US National Human Genome Research Institute
- UCSF Center for Maternal Fetal Precision Medicine
Zitieren
APA
Shear, M. A., Borges, B., Lianoglou, B. R., Lum, T., Canepa, E., Cohen, J. L., Brown, J. E. H., & Herzeg, A. (2026). The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations. Prenatal Diagnosis. https://doi.org/10.1002/pd.6890
Vancouver
Shear MA, Borges B, Lianoglou BR, Lum T, Canepa E, Cohen JL, et al. The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations. Prenatal Diagnosis. 2026. doi:10.1002/pd.6890
BibTeX
@article{Shear2026,
author = {Shear, Matthew A and Borges, Beltran and Lianoglou, Billie R and Lum, Tony and Canepa, Emma and Cohen, Jennifer L and Brown, Julia E H and Herzeg, Akos},
title = {The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.6890}
}
EUVIMED